Health TrialsbyHealthPanel

Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department

ConditionHead Pain
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18-85
SponsorUniversity of Monastir

About this trial

Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

informed consent

age >18 years

Acute non-traumatic acute headaches

patients treated in ED

Disqualifiers

Current regular use of analgesics, anticonvulsants or antidepressants

Renal disorder with a low glomerular filtration rate (<60 ml/min)

Neuromuscular disorder

Pregnant woman

Trial design

Design model

Parallel

Treatments tested in this trial

  • Magnesium sulfate

    Drug

    magnesium group 1g paracetamol + 20 min infusion of 2 g magnesium in 150 ml of saline serum and Placebo Group 1g paracetamol + 20 min infusion of 150 ml of saline serum

Treatment groups

424 Participants
are divided into 2 treatment groups
Group A: Placebo GroupPlacebo comparator 1 intervention
Group B: magnesium groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Intravenous Magnesium Sulfate to Treat Non -Traumatic Acute Headaches in the Emergency Department

Patients with Non -Traumatic Acute Headaches in the Emergency Department recived 1g paracetamol + 20 min infusion of 2g magnesium

Time frame
1day

Secondary outcomes

1

Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department

Patients with Non -Traumatic Acute Headaches in the Emergency Department received 1g paracetamol + 20 min infusion of saline serum

Time frame
1 day

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Monastir

Lead sponsor

Source ClinicalTrials.gov
Apply now